We observed robust cytotoxicity of CD38 CAR‐T cells against primary T‐ALL cells (Figure 4B), resulting in more than 70% elimination of T‐ALL cells for both patient samples (Figure 4C). This evidence concerns the gene CD38 and acute lymphoblastic leukemia.